Economía de los medicamentos genéricos en América Latina
Date
2008Author
Metadata
Show full item recordAbstract
In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic drugs from the economic perspective by examining various regulatory models in order to evaluate and leverage generic drug policy implementation options as a mechanism for battling some of the markets specific weaknesses. The conclusion is that there is no single unequivocal method for promoting the use of generic drugs, and that the most favorable way to integrate markets may be through a broad combination of alternatives. These alternatives are grouped and analyzed according to the market issues or challenges that must be overcome. Several options are then identified based on the degree of market consolidation to be obtained.(AU)
Translated title
Economy of generic drugs in Latin America
Subject
URI
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000100008https://iris.paho.org/handle/10665.2/7739
Citation
Tobar, Federico (2008) Economía de los medicamentos genéricos en América Latina. Rev Panam Salud Publica;23(1) 59-67,ene. 2008. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000100008
Collections
Related items
Showing items related by title, author, creator and subject.
-
Fonseca, Elize Massard da (2015)
-
Pan American Health Organization (1992)Incluye lista de participantes
-
Tobar, Federico; Drake, Ignacio; Martich, Evangelina (2012)